Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer: Update

ISSN： 1567-2034

Source： Medicinal Chemistry Reviews - Online, Vol.1, Iss.3, 2004-01, pp. : 253-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bonafide Targets of Deregulated microRNAs in Non-Small Cell Lung Cancer as Tool to Identify Novel Therapeutic Targets: A Review

Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. : 55-72

Bentham Science Publishers

Access to resources Recommend Favorite

Non-canonical IKKs, IKKε and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer

By Kim Jae-Young Beg Amer A Haura Eric B

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1109-1112

Informa Healthcare

Access to resources Recommend Favorite

Erlotinib: a new therapeutic approach for non-small cell lung cancer

By Bonomi Philip

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1395-1401

Informa Healthcare

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pemetrexed for the treatment of non-small cell lung cancer

By Genova Carlo

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1545-1558

Informa Healthcare

Access to resources Recommend Favorite